ERBB2 and lung carcinoma: ERBB2 (Her2/neu) exon 20 insertions and a few point mutations have been reported in 4% (34) of cases of lung adenocarcinoma in The Cancer Genome Atlas (TCGA) database and 3% of cases in the Lung Cancer Mutation Consortium project (35).